Albumin-bound toxin

"Albumin-bound toxins" is not the name of a specific molecule or therapeutic target but rather refers to various endogenous and exogenous toxic substances that are transported in the bloodstream by binding to serum albumin. Albumin is the most abundant plasma protein and serves as a carrier for many compounds—including fatty acids, hormones, bilirubin (a heme breakdown product), drugs like warfarin and ibuprofen, and numerous uremic toxins[2][7]. In conditions such as chronic kidney disease or liver failure, these protein-bound toxins accumulate due to impaired clearance mechanisms. This accumulation poses clinical challenges because only the unbound fraction of both drugs and toxins is pharmacologically active or available for elimination; thus high levels of bound substances can act as reservoirs that prolong exposure[1][5]. While therapies exist that attempt to remove these bound molecules—such as specialized dialysis techniques—there is no single receptor or molecular entity called "albumin-bound toxin." The term describes a class of molecules associated with pathophysiology rather than a discrete druggable target. In summary: "Albumin-bound toxin" should not be considered an individual therapeutic target but rather describes any toxic compound carried by serum albumin. The correct canonical form would refer instead either to specific types of protein-binding transporters ("Serum albumin") or individual toxic ligands themselves.

Other names

Protein-bound toxinAlbumin-associated toxinProtein-bound uremic toxin (for kidney disease context)

Not applicable; drugs do not directly target "albumin-bound toxins" as a molecular entity. Some therapies aim to displace or remove these toxins from albumin in extracorporeal treatments.